Literature DB >> 25056265

Dabigatran, bleeding, and the regulators.

Thomas J Moore1, Michael R Cohen2, Donald R Mattison3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056265     DOI: 10.1136/bmj.g4517

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  23 in total

1.  Data informs debate.

Authors:  Elizabeth Roughead
Journal:  Aust Prescr       Date:  2015-04-01

Review 2.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

3.  Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres.

Authors:  Aleesa A Carter; Kori Leblanc; Amita Woods; Donna Lowe
Journal:  Can J Hosp Pharm       Date:  2015 Sep-Oct

4.  Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.

Authors:  Anne Katrine Eek; Erik Øie; Anne Gerd Granas
Journal:  Eur J Clin Pharmacol       Date:  2017-11-17       Impact factor: 2.953

5.  The hazards of rapid approval of new drugs.

Authors:  Jennifer Martin; Gillian Shenfield
Journal:  Aust Prescr       Date:  2016-02-01

6.  Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort study.

Authors:  Kerstin Hogg; Bharat Bahl; Meriem Latrous; Sarina Scaffidi Argentina; Jesse Thompson; Aasil Ayyaz Chatha; Lana Castellucci; Ian G Stiell
Journal:  CMAJ Open       Date:  2015-12-04

Review 7.  The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio.

Authors:  Apostolos Safouris; Nikos Triantafyllou; John Parissis; Georgios Tsivgoulis
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

Review 8.  Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation.

Authors:  Francesco Violi; Daniele Pastori; Pasquale Pignatelli
Journal:  J Atr Fibrillation       Date:  2014-10-31

Review 9.  Periprocedural management of patients receiving novel oral anticoagulants.

Authors:  Paloma Arias Pou; Aquerreta González; Luis José Prieto Martínez; Amaya Delgado Latorre; María Serrano Alonso
Journal:  Eur J Hosp Pharm       Date:  2017-02-23

10.  The Dabigatran debate.

Authors:  Riyaz A Kaba; Farhana Ara; David E Ward; Subo Emanuel
Journal:  Glob Cardiol Sci Pract       Date:  2014-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.